BCAB
BioAtla, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.74
+2.66%Leverage
- Debt / equity
- -0.16x
- Net debt / equity
- -0.12x
- Debt / assets
- 0.62x
- Debt / EBITDA
- -0.20x
- Net debt / EBITDA
- -0.15x
Liquidity & coverage
- Current ratio
- 0.20x
- Quick ratio
- 0.20x
- Cash ratio
- 0.07x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -$16.8M
Cash & dividend
- FCF / debt
- -4.01x
- Cash flow / debt
- -4.01x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026